Immunity booster supplement market is anticipated to grow at a significant CAGR during the forecast period. The key factor contributing to the market growth includes the rising awareness among consumers for immunity boosters that are capable of fighting against infectious diseases. These boosters majorly include the vitamins, minerals, herbal extracts, and omega-3 fatty acids supplements […]
Category Archives: Pharmaceuticals
Fondaparinux Market is estimated to grow at a CAGR of nearly 7.5% during the forecast period. Significant rise in the prevalence of arthritis is primarily driving the global fondaparinux market. As per the Centers for Disease Control and Prevention (CDC), by 2040, the number of adults aged 18 years and over in the US with doctor-diagnosed […]
Heterozygous familial hypercholesterolemia drug market is anticipated to grow at a significant CAGR during the forecast period. Heterozygous familial hypercholesterolemia (HeFH) is an inherited genetic disorder. It causes high cholesterol levels that lead to heart disease, heart attack, or stroke. Additionally, HeFH is one form of Familial Hypercholesterolemia (FH). The major factor driving the demand […]
US Neurological Disorder Drugs Market is anticipated to grow significantly over the forecast period. The rising prevalence of neurological disorders coupled with the rising geriatric population tends to drive the growth of the market. In addition, the launch of novel products by the key players across the globe further supports the growth of the market. […]
North American neurological disorder drug is projected to grow at a significant CAGR during the forecast period. The key factors that drive the growth of the market include the rising prevalence of neurological disorders among people across the globe. The rising geriatric population is another major reason for market growth in the North American region. […]
Indian neurological disorder drugs market is anticipated to grow significantly over the forecast period. The key factor that primarily flourishes the growth of the Indian neurological disorder drugs industry includes the rising prevalence of neurological disorders. There is an increased burden of neurological disorders in the country, along with the lack of skilled personnel for […]
European neurological disorder drugs market is anticipated to grow significantly over the forecast period. The key factors that primarily flourish the growth of the market include the rising geriatric population along with the rising prevalence of neurological disorders. As per the European Academy of Neurology 2019, around 60% of the population suffers from any one […]
Asia-Pacific neurological disorder drugs market is projected to grow at a significant CAGR during the forecast period. The key factors driving the growth of the market include the rising geriatric population, increased prevalence of neurological disorders coupled with the development of novel drugs and technologies for drug development. In the Asia-Pacific region, economies such as […]
Sotalol Market is anticipated to grow at a significant CAGR during the forecast period. Sotalol, a methanesulfonamide, is a class III antiarrhythmic drug that belongs to a group of medicines called beta-blockers and is used for the treatment of atrial fibrillation and other conditions that cause an irregular heartbeat (arrhythmia). It is used to support […]
Quinidine Sulfate Market is anticipated to grow at a significant CAGR during the forecast period. Quinidine sulfate is used for the treatment of certain types of irregular heartbeats. It is in a class of medications called antiarrhythmic medications and works by making the heart more resistant to abnormal activity. The major factor driving the demand […]